Síndrome de hipertermia maligna: una patología infrecuente

  • García-Muro C
  • Sáenz-Moreno I
  • Riaño-Méndez B
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Background: Malignant hyperthermia syndrome is a hereditary pharmacogenetic disorder of skeletal muscle characterized by hypermetabolic state related to the exposure of volatile anesthetic gases or depolarizing muscle relaxants. It is an infre-quent entity that occurs in genetically predisposed individuals, with a very low incidence in pediatrics (1 in 10,000-15,000 anesthetic procedures). Case report: We report a case of malignant hyperthermia related to exposure to sevoflurane during adenoidectomy surgery in a 6-year-old female. The patient presented with tachycardia, hypercapnia, and hyperthermia, requi-ring two successive doses of dantrolene sodium administration, with an adequate response to the treatment. Conclusions: Malignant hyperthermia syndrome is a rare condition in pediatric patients that should be detected in early stages since it is essential to initiate the treatment as soon as possible.

Cite

CITATION STYLE

APA

García-Muro, C., Sáenz-Moreno, I., Riaño-Méndez, B., Gutiérrez-Delgado, J. M., Valencia-Ramos, J., & Esteban-Zubero, E. (2020). Síndrome de hipertermia maligna: una patología infrecuente. Boletín Médico Del Hospital Infantil de México, 77(6). https://doi.org/10.24875/bmhim.20000047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free